Crescent Innovations Inc. announced today the sale of its
technology related to skin regeneration, plus various intellectual
property and know-how assets.
WESTFORD, Mass., May 14, 2024
/PRNewswire-PRWeb/ -- Crescent Innovations Inc. announced
today the sale of its technology related to skin regeneration, plus
various intellectual property and know-how assets. Chris Finn, President of the advisory firm
Alternotio announced today that Crescent Innovations has retained
Alternotio to sell the assets using a sealed bid sales process on
June 28, 2024.
"The technology allows for a simple day
procedure to harvest keratinocytes, embed them in a delivery
matrix, and deliver them to the wound site."
The global wound care market size was estimated at USD 22.25 billion in 2023 and is projected to
grow at a compound annual growth rate (CAGR) of 4.17% from 2024 to
2030. The demand for wound care products is increasing owing to the
increasing number of surgical cases and the rising prevalence of
chronic diseases across the globe. Furthermore, the increasing
incidence of diabetes due to a sedentary lifestyle is one of the
leading factors contributing to market growth. For instance, as per
a report by Centers for Disease Control and Prevention (CDC), which
was last reviewed in April 2023, 37.3
million Americans have diabetes. Similarly, as per the same source,
96 million American adults have prediabetes.
Crescent Innovations has developed a new trade secret protected
method for autologous keratinocyte wound care. This is enabled by
Crescent Innovations' patent US7371399B2. The technology allows for
a simple day procedure to harvest keratinocytes, embed them in a
delivery matrix, and deliver them to the wound site. This
technology showed superior performance to all standard practices in
an in vitro model for wound healing.
The assets will be sold at a sealed bid sale on June 28, 2024, at noon. Parties interested in
purchasing any or all of the assets must sign a confidentiality
agreement, which can be obtained by contacting Chris Finn at info@alternotio.com or calling +1
(978) 882 - 2586. Negotiated offers are welcome, but any negotiated
sale must be concluded prior to opening bids on the date specified
above and must conform to the terms set forth for sealed bids.
About Crescent Innovations Inc.
Crescent Innovations Inc. is a firm focused on the development
of biological polymers to create non surgical regenerative
solutions for chronic conditions. The firm currently is focused on
innovating technology to solve TMJ disorders and singular maladies.
If interested in TMJ disorders, please contact Crescent Innovations
directly at www.crescentinnovations.com
About Alternotio.
Alternotio is an advisory firm, that specializes in the sale of
non-lead and distressed intellectual property. Alternotio
occasionally works with unique tangible assets that have a
substantial intellectual property component.
Media Contact
Al Prescott, Crescent
Innovations, INC., 1 978.764.8604,
alprescott@crescentinnovations.com,
www.crescentinnovations.com
View original
content:https://www.prweb.com/releases/crescent-innovations-offers-enabling-technology-for-skin-growth-and-its-impact-on-wound-care-burn-care-and-diabetic-ulcers-302143173.html
SOURCE Crescent Innovations, INC.